The Expanding Care in the Home Act establishes new payment models for Medicare home-based care services. It would allow primary care providers to receive monthly capitated payments instead of fee-for-service, expand coverage for home infusion therapy and staff-assisted home dialysis, and create new reimbursement for in-home lab tests and advanced diagnostic imaging. The bill also establishes coverage for personal care services (up to 12 hours weekly) and funds workforce development programs for home-based care providers. These changes would directly affect Medicare beneficiaries needing home care and the healthcare providers who deliver those services. The legislation aims to improve access to coordinated care in home settings through new payment structures and expanded service coverage.
This bill eliminates copays and deductibles for Medicare Part B beneficiaries receiving chronic care management services starting January 1, 2024. It directly affects Medicare patients with chronic conditions who use these specific management services. The key provision amends Medicare payment rules to require 100% coverage for these services, removing both patient cost-sharing and the application of deductibles. This change applies only to services described under Section 1848(b)(8) of the Social Security Act.
The I CAN Act (Improving Care and Access to Nurses Act) expands healthcare access by removing barriers for nurse practitioners, clinical nurse specialists, physician assistants, certified registered nurse anesthetists, and certified nurse-midwives within Medicare and Medicaid programs. Key provisions include allowing these professionals to provide cardiac and pulmonary rehabilitation services, prescribe certain diabetic shoes, and deliver hospice care without unnecessary physician supervision. The bill also clarifies reimbursement for services provided by certified nurse anesthetists and improves access to home health services through certified nurse-midwives. These changes directly affect Medicare and Medicaid beneficiaries by potentially increasing access to care and healthcare providers by expanding their scope of practice. The bill aims to improve healthcare delivery by leveraging the skills of advanced practice nurses across multiple care settings.
This bill establishes a new workplace violence prevention standard for healthcare and social service workers. It requires employers in covered facilities - including hospitals, nursing homes, mental health clinics, and social service settings - to develop and implement comprehensive prevention plans with specific requirements. These plans must include risk assessments, hazard prevention measures, employee training on violence prevention, and procedures for reporting and investigating violent incidents. The bill also amends Medicare regulations to require compliance with these standards for hospitals and skilled nursing facilities receiving Medicare funds.
The Pharmacy Benefits Manager Accountability Act requires pharmacy benefits managers (PBMs) and health insurance issuers to provide detailed annual reports to plan sponsors (like employers) about drug spending, rebates, and formulary decisions. These reports must include specific data on drugs dispensed, costs, patient out-of-pocket spending, rebates received from manufacturers, and net spending after rebates, all in machine-readable format. The bill establishes penalties of up to $10,000 per day for failure to provide required information and $100,000 per item for false information. It also directs a GAO study on pharmacy networks and common ownership structures to assess potential anti-competitive practices.
HR 2474, the "Strengthening Medicare for Patients and Providers Act," changes how Medicare pays physicians for services. It replaces the previous two-part payment system (used through 2025) with a single annual payment rate update starting in 2024. This update will be based on the Medicare Economic Index (MEI), which tracks costs for medical providers. The change directly affects Medicare-certified doctors and clinics who receive payments under the physician fee schedule.
This bill would require Medicare to cover FDA-approved blood tests that screen for multiple cancers simultaneously (like breast, lung, or colorectal cancer) for beneficiaries. It directly affects Medicare recipients aged 65+ who could access these new screenings once per year, without prior authorization. The key provision adds "multi-cancer early detection screening tests" to Medicare's covered services under Part B, defining them as blood tests analyzing cell-free DNA, while maintaining existing coverage for standard screenings like mammograms. The bill does not change current coverage for individual cancer screenings but ensures Medicare keeps pace with new medical technology.
This bill modifies Medicare's rules for clinical laboratory testing to reduce administrative burdens. It requires the use of statistically valid sampling (instead of full reporting) for "widely available" tests - defined as tests costing under $1,000 per test with over 100 labs performing them - to determine payment rates starting in 2026. The bill also delays reporting deadlines until 2027, updates how labs are defined for payment purposes, and adds annual payment increase caps (2.5% for common tests in 2024-2025, rising to 5% by 2028). These changes directly affect Medicare-participating labs, particularly independent and hospital-based labs conducting common tests.
This bill requires Medicare, Medicaid, and CHIP to cover advanced genetic cancer testing (like DNA/RNA sequencing and their interpretation) for patients diagnosed with cancer. It defines covered tests as next-generation sequencing performed by clinical labs and limits coverage to once per diagnosis, recurrence, or treatment monitoring. Medicare will pay 80% of the test cost (or 100% if billed under assignment), while Medicaid and CHIP must include these tests in mandatory coverage starting January 1, 2025. The bill directly affects cancer patients enrolled in these federal health programs by ensuring access to specific genetic testing without excessive out-of-pocket costs.
This bill expands Medicare Part B coverage to include specific pharmacist services, directly affecting Medicare beneficiaries and pharmacists who provide these services. It adds new coverage for pharmacist evaluations and treatments related to certain illnesses (like COVID-19, flu, or strep throat) and public health emergencies, requiring payment at 80% of the lesser of actual charge or 85% of physician payment rates (100% during emergencies). The bill also prohibits balance billing for these services, ensuring beneficiaries pay only the standard Medicare copayment. These changes aim to improve access to pharmacist care during health crises while aligning payment with existing physician service frameworks.
HR 1692, the Health Care Affordability Act of 2023, adjusts how health insurance subsidies are calculated for people buying coverage through the marketplace. It replaces the previous subsidy formula with a sliding scale based on income, where households earning up to 150% of the poverty line pay 0% of premiums, and those at 400% or more pay 8.5%. The change applies to all income tiers between these points, with percentages increasing incrementally (e.g., 2% for 150-200% income). This directly affects individuals purchasing health insurance through the marketplace who qualify for subsidies under the Affordable Care Act. The bill amends Section 36B of the Internal Revenue Code and takes effect for tax years beginning after December 31, 2022.
The E-BIKE Act establishes a 30% tax credit for individuals purchasing qualified electric bicycles, with a maximum credit of $1,500 per bicycle (30% of the $5,000 cost limit). To qualify, bicycles must meet specific safety standards including speed limits (20 mph for classes 1-2, 28 mph for class 3), pedal assistance requirements, and safety certifications like UL 2849. The credit phases out for higher-income taxpayers, beginning at $150,000 modified adjusted gross income for single filers, $225,000 for heads of household, and $300,000 for joint filers. The bill also includes a provision allowing retailers to claim the credit directly when selling qualifying bicycles, reducing the upfront cost for consumers.
